Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenjiao Yang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|August 22, 2025
PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted CancersBang Li, Jin-Qi Yu, Zhenjiao Yang, et al.
Medicinal Research Reviews|May 14, 2026
STING: An Attractive Target for Autoimmune and Inflammatory DiseasesZhenjiao Yang, Xinqiao Liu, Jinhong Zhan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 29, 2025
Identifying the Core Symptoms in Chinese Patients of Chronic Obstructive Pulmonary Disease: A Contemporaneous Symptom Network AnalysisZhenjiao Yang, Miaoling Cui, Jianquan Zhang, et al.
Journal of Pain and Symptom Management|April 11, 2020
Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseZhenjiao Yang, Miaoling Cui, Xiaofang Zhang, et al.
The Journal of Organic Chemistry|November 24, 2021
Hydrazine Hydrate Accelerates Neocuproine-Copper Complex Generation and Utilization in Alkyne Reduction, a Significant Supplement Method for Catalytic HydrogenationYongsheng Zhang, Jincheng Wang, Zhenjiao Yang, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2025
Discovery of N-methylguanidine derivatives as a new type of potent pyruvate kinase M2 inhibitorWeiguo Zhang, Zhenjiao Yang, Xingxing Li, et al.
Journal of Medicinal Chemistry|September 4, 2024
Discovery of a Highly Potent and Selective Inhibitor Targeting Protein Lysine Methyltransferase NSD2Jianwei Wei, Qiongyu Shi, Bang Li, et al.
Journal of Medicinal Chemistry|July 15, 2024
Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid TumorsChunju Yang, Bang Li, Zongbo Feng, et al.
Cell Death & Disease|June 17, 2026
Targeting STAT3-mediated lipid metabolism reprogramming overcomes chemoresistance in acute myeloid leukemiaKeren Peng, Jianshan Mo, Zhenjiao Yang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|August 22, 2025
PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted CancersBang Li, Jin-Qi Yu, Zhenjiao Yang, et al.
Medicinal Research Reviews|May 14, 2026
STING: An Attractive Target for Autoimmune and Inflammatory DiseasesZhenjiao Yang, Xinqiao Liu, Jinhong Zhan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 29, 2025
Identifying the Core Symptoms in Chinese Patients of Chronic Obstructive Pulmonary Disease: A Contemporaneous Symptom Network AnalysisZhenjiao Yang, Miaoling Cui, Jianquan Zhang, et al.
Journal of Pain and Symptom Management|April 11, 2020
Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseZhenjiao Yang, Miaoling Cui, Xiaofang Zhang, et al.
The Journal of Organic Chemistry|November 24, 2021
Hydrazine Hydrate Accelerates Neocuproine-Copper Complex Generation and Utilization in Alkyne Reduction, a Significant Supplement Method for Catalytic HydrogenationYongsheng Zhang, Jincheng Wang, Zhenjiao Yang, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2025
Discovery of N-methylguanidine derivatives as a new type of potent pyruvate kinase M2 inhibitorWeiguo Zhang, Zhenjiao Yang, Xingxing Li, et al.
Journal of Medicinal Chemistry|September 4, 2024
Discovery of a Highly Potent and Selective Inhibitor Targeting Protein Lysine Methyltransferase NSD2Jianwei Wei, Qiongyu Shi, Bang Li, et al.
Journal of Medicinal Chemistry|July 15, 2024
Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid TumorsChunju Yang, Bang Li, Zongbo Feng, et al.
Cell Death & Disease|June 17, 2026
Targeting STAT3-mediated lipid metabolism reprogramming overcomes chemoresistance in acute myeloid leukemiaKeren Peng, Jianshan Mo, Zhenjiao Yang, et al.
Pageof 1